M H de Groot. Show Affiliations »
Abstract
Mesh： See more » AgedAgingAnti-Anxiety Agents/therapeutic useAntidepressive Agents/therapeutic useAntipsychotic Agents/therapeutic useAnxiety/drug therapyBenzodiazepinesBipolar Disorder/drug therapyButyrophenones/therapeutic useDepression/drug therapyHaloperidol/therapeutic useHumansHypnotics and Sedatives/therapeutic useLithium/therapeutic useMental Disorders/diagnosisMental Disorders/drug therapyMonoamine Oxidase Inhibitors/therapeutic useNeurocognitive Disorders/drug therapyPhenothiazinesPsychotropic Drugs/adverse effectsPsychotropic Drugs/therapeutic useSchizophrenia/drug therapySleep Initiation and Maintenance Disorders/drug therapy
Substances： See more » Anti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsButyrophenonesHypnotics and SedativesMonoamine Oxidase InhibitorsPhenothiazinesPsychotropic DrugsBenzodiazepinesLithiumHaloperidol
Year: 1974 PMID： 4154836 DOI： 10.2165/00003495-197408020-00006
Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546